Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD 20892, USA.
Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.
Cell Rep. 2018 Feb 13;22(7):1798-1809. doi: 10.1016/j.celrep.2018.01.023.
Highly effective HIV-1-neutralizing antibodies could have utility in the prevention or treatment of HIV-1 infection. To improve the potency of 10E8, an antibody capable of near pan-HIV-1 neutralization, we engineered 10E8-surface mutants and screened for improved neutralization. Variants with the largest functional enhancements involved the addition of hydrophobic or positively charged residues, which were positioned to interact with viral membrane lipids or viral glycan-sialic acids, respectively. In both cases, the site of improvement was spatially separated from the region of antibody mediating molecular contact with the protein component of the antigen, thereby improving peripheral semi-specific interactions while maintaining unmodified dominant contacts responsible for broad recognition. The optimized 10E8 antibody, with mutations to phenylalanine and arginine, retained the extraordinary breadth of 10E8 but with ∼10-fold increased potency. We propose surface-matrix screening as a general method to improve antibodies, with improved semi-specific interactions between antibody and antigen enabling increased potency without compromising breadth.
高效的 HIV-1 中和抗体在 HIV-1 感染的预防或治疗中可能具有实用性。为了提高 10E8 的效力,10E8 是一种能够近乎广谱中和 HIV-1 的抗体,我们对其表面突变体进行了工程改造,并筛选出具有改善中和作用的变体。功能增强最大的变体涉及添加疏水性或带正电荷的残基,这些残基分别定位于与病毒膜脂质或病毒糖基唾液酸相互作用。在这两种情况下,改进的部位与抗体介导与抗原蛋白成分分子接触的区域在空间上分离,从而改善外周半特异性相互作用,同时保持负责广泛识别的未修饰主要接触。经过苯丙氨酸和精氨酸突变优化的 10E8 抗体保留了 10E8 的非凡广度,但效力提高了约 10 倍。我们提出表面基质筛选作为一种通用的抗体改进方法,抗体与抗原之间改善的半特异性相互作用使效力提高而不损害广度。